Psychotic Disorder
54
8
9
32
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
11 trials with published results (20%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.3%
5 terminated out of 54 trials
86.5%
-0.0% vs benchmark
22%
12 trials in Phase 3/4
34%
11 of 32 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 32 completed trials
Clinical Trials (54)
Cognitive Strategies in Early Psychosis 2
Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability
Psychotropic-Drug-induced QT Prolongation and ECG Monitoring in the Pediatric Population
Arts-based Social Prescribing for Mental Health
The Effectiveness of Forest Therapy on Psychotic Patients: Focusing on Changes in Inflammatory Pathways and The Psychotic Condition of Patients
Brain Stimulation to the Hippocampus in Schizophrenia
Changing Lives and Changing Outcomes-9 at Worcester Recovery Center and Hospital
Speech-based Assessment of Relapse Risk in People With Psychosis
Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy
Deprescribing Antipsychotics: a Multiple Case Study
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
Effects of a Long-term Exercise Training Program on the Functional Capacity and Health-related Quality of Life in Inpatients With Psychotic Disorders
Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial
A Cannabis Harm Reduction e-Intervention for Young Cannabis Users With Early Psychosis
Mobile After-Care Support App: Pilot RCT
Mindfulness-Based Family Psychoeducation Intervention for Early Psychosis
Delusion Ideation in the Context of Everyday Life
Peer Support for Exercise in Older Veterans With Psychotic Disorders
tDCS for Cognitive Impairment Associated With Recent-onset Schizophrenia
The Impact of Gaming on Functioning Among People With Schizophrenia